Medpace, a privately held, full-service CRO, has acquired Medical Consulting Dr. Schlichtiger GmbH, a Munich-based CRO that provides customized regulatory and pharmacovigilance services to pharmaceutical, biotechnology and nutritional companies. The acquisition provides Medpace with centralized European hubs for regulatory submissions and approvals as well as drug safety management and reporting. Medical Consulting is led by Dr. Ursula Schlichtiger, general manager and research professional....